The cell surface proteome acts as the key point of contact between diseased cells and their surrounding microenvironment, making it a valuable source of potential therapeutic targets and diagnostic biomarkers. By systematically mapping the cell surface proteome, researchers can move beyond guesswork to discover targets that are truly tumor‑relevant while minimizing impact on healthy tissues.
In this Biocompare webinar, experts Fabiana Perna and Arun Wiita will show how cell surface proteome profiling can directly accelerate target discovery for immunotherapies. They will walk through real research examples that connect experimental strategies and analytical tools to concrete decisions about which antigens to pursue.
Topics to be discussed in this webinar
- How recent advances in cell surface proteome mapping are transforming target discovery for cancer therapies.
- Practical methods and technologies used to identify actionable targets on the surface of cancer cells.
- Strategies to prioritize and refine target antigens for next‑generation immunotherapies.
- Case examples showing how surfaceome research is revealing new therapeutic targets in multiple myeloma and acute myeloid leukemia.
Register today to gain valuable insights into how investigations of the cell surface proteome are driving the development of more effective, personalized cancer treatments.